Engineered immunity
Built by nature, engineered by Anocca
Engineered immunity
Built by nature, engineered by Anocca
Anocca is creating a pipeline of precision T-cell immunotherapies by combining its novel approach to T-cell biology, cutting-edge biotechnologies and integrated software
Approach
Our science
We’ve built novel biotechnologies to replicate T-cell biology in the lab and combined it with custom software providing precise analyses to identify disease targets and build T-cell immunotherapies.
Go to our scienceTCR-T Oncology
Pipeline
Our primary focus is to engineer TCR-T cell therapies for untreatable cancers. T-cell receptor engineered T-cell therapy (TCR-T) harnesses the natural ability of T-cells to recognise disease targets from inside cancer cells, opening a rich and largely unexplored source of therapeutic targets for precision cancer therapeutics.
Go to pipeline